Clinical trials
Completed Observational Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Italiana Sindromi Mielodisplastiche-ETS | 3 |
| University of California, San Francisco | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beth Israel Medical Center | 1 |
| Children's Oncology Group | 1 |
| Duke University | 1 |
| Saint-Louis Hospital, Paris, France | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 11 |
| Anemia, Aplastic | 3 |
| Hematologic Neoplasms | 2 |
| Leukemia | 2 |
| Lymphoma | 2 |
| Neoplasms, Plasma Cell | 2 |
| Anemia, Refractory | 1 |
| Anemia, Sickle Cell | 1 |
| Carcinoma, Renal Cell | 1 |
| Fanconi Anemia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.